Chimeric Antigen Receptor (Car) T Cell Immunotherapy Market Competitive Landscape, Technology and Pipeline Analysis Research Report 2016

Researchmoz added Most up-to-date research on "Chimeric Antigen Receptor (CAR) T cell Immunotherapy - Competitive Landscape, Technology and Pipeline Analysis, 2016" to its huge collection of research reports.

DelveInsight Report, “Chimeric Antigen Receptor (CAR) T cell Immunotherapy- Competitive Landscape, Technology and Pipeline Analysis, 2016” emphasizes on the currently active CAR-T cell products in research and development. The Report covers the 40+ companies which are active in this field including 27 leading companies with 101 products targeting 44 different antigens and 24 different technologies. The Report provides in-depth analysis on the CAR-T cell profiles covering pre-clinical and clinical studies, Collaborations details and Deal values, Technologies and Targeted antigens. The Report provides the CAR-T licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis. Report also describes the unmet needs covered by CAR-T cells highlighting the adverse events, which are major concerns in the market for the usage of CAR-T cells.

Report Highlights:

CAR-T cell Therapy Pipeline scenario

Collaborations & partnering deals

Current Prominent Research Areas and Key Players

Pipeline product profiles CAR-T Technologies and Targeted Antigens

Licensing opportunities

Market Drivers and Barriers

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=522288

Scope

Overview of the global CAR-T cell therapy pipeline scenario, products and associated companies information

Coverage of global CAR-T cell therapies under development

Competitive landscape of products for key players and related indications

Coverage of licensors, collaborators and Development partners, deal terms and deal values estimation

Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles,...